Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 55 (5) , 524-530
- https://doi.org/10.1016/j.biopsych.2003.10.014
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The amyloid‐β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Aβ peptideRapid Communications in Mass Spectrometry, 2003
- Cerebrospinal fluid τ and β-amyloid(1-42) in dementia disordersMechanisms of Ageing and Development, 2001
- Molecular Biology of Alzheimer’s Dementia and Its Clinical Relevance to Early Diagnosis and New Therapeutic StrategiesGerontology, 2001
- The role of cholesterol in the biosynthesis of β-amyloid.NeuroReport, 1999
- The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase ActivitiesPublished by Elsevier ,1996
- Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot AssayJournal of Biological Chemistry, 1996
- β-Amyloid Precursor ProteinJournal of Biological Chemistry, 1996
- Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal FluidJournal of Neurochemistry, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975